Last reviewed · How we verify
Anterior uveitis
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Lotemax · Bausch Health
- Tobi · Novartis
- Lotemax · Tufts Medical Center
- Decadron · Generic (originally Merck)
- Vantobra · Pfizer
- Nebcin · University Hospital, Lille
Clinical guidelines
- FDA label — 1L
Dexamethasone is indicated for the treatment of anterior uveitis.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Anterior uveitis patent landscape — cliff calendar, originator estates, attackable patents
- Anterior uveitis treatment landscape brief
- Anterior uveitis treatment updates RSS
Frequently asked questions about Anterior uveitis
What drugs treat Anterior uveitis?
Tracked treatments include Ramycin, Lotemax, Tobi, Decadron, Vantobra, Nebcin.
What is the treatment for Anterior uveitis?
Standard treatment for Anterior uveitis includes Ramycin, Lotemax, Tobi, Decadron, Vantobra. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Anterior uveitis?
FDA label publishes guidelines for Anterior uveitis. 1 guideline references tracked.
Related
- Treatment landscape: Anterior uveitis patent cliff · Anterior uveitis CI report
- Treatment: Ramycin
- Treatment: Lotemax · Bausch Health
- Treatment: Tobi · Novartis
- Treatment: Lotemax · Tufts Medical Center
- Treatment: Decadron · Generic (originally Merck)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing